Results 121 to 130 of about 5,948 (206)
Aims: The spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7) are clinically characterized by progressive and severe ataxic symptoms, dysarthria, dysphagia, oculomotor impairments, pyramidal and extrapyramidal manifestations and sensory
Sch\uf6ls, L. +19 more
core +1 more source
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
Protein cleavage is a common feature in human neurodegenerative disease. Ataxin-3 protein with an expanded polyglutamine (polyQ) repeat causes spinocerebellar ataxia type-3 (SCA3), also called Machado–Joseph disease, and is cleaved in mammalian cells ...
Derek Lessing +3 more
core
The ATXN2 9 bp duplication in SCA3: clarifying evidence and correcting misinterpretations. [PDF]
Laffita-Mesa JM +2 more
europepmc +1 more source
Autosomal dominant spinocerebellar ataxias (SCAs) are a heterogeneous group of progressive neurodegenerative disorders. SCAs are clinically characterized by mainly cerebellar ataxia, resulting in unsteady gait, clumsiness, and dysarthria and but can ...
Lehmann, Anna
core
Somatosensory Evoked Potentials in Spinocerebellar Ataxia Type 3 and Type 10. [PDF]
Coutinho L +11 more
europepmc +1 more source
BACKGROUND: Cognitive deficits are common in spinocerebellar ataxia type 3 (SCA3), but their neurobiological correlates remain largely unknown. OBJECTIVES: To investigate cognitive performance in a large international cohort of SCA3 mutation carriers ...
Faber, Jennifer +19 more
core
Spinocerebellar ataxia type 1 (SCA1), spinocerebellar ataxia type 2 (SCA2) and Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3) are three distinctive forms of autosomal dominant spinocerebellar ataxia (SCA) caused by expansions of an ...
Cardoso, Francisco +21 more
core
Peripheral and autonomic nervous system involvement in spinocerebellar ataxia type 3: unveiling an invisible burden. [PDF]
Leeuwenberg KE +3 more
europepmc +1 more source
Extracellular vesicles-mediated delivery of SpCas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3. [PDF]
Leandro K +15 more
europepmc +1 more source
Polyglutamine-Expanded Ataxin-3 Accelerates CFTR Degradation Through K63-Linked Ubiquitination to Exacerbate Microglial Inflammation. [PDF]
Wang Z +11 more
europepmc +1 more source

